{'fraction_non_alphanumeric': 0.018535681186283594, 'fraction_numerical': 0.0018535681186283596, 'mean_word_length': 5.506024096385542, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Resolution of Post-Molar Pregnancy Uterine Arteriovenous Malformation Following Treatment with GnRH Agonist Concomitantly with an Aromatase Inhibitor and Tranexamic Acid

Background: Acquired uterine arteriovenous malformations (AVM) are a rare but potentially serious 
condition that can result in severe bleeding. Rarely, uterine AVM can occur following a complete molar 
pregnancy. Resolution of AVMs has been reported recently with conservative management using a 
combination of Gonadotropin-Releasing Hormone (GnRH) agonist, an aromatase inhibitor and tranexamic 
acid. This treatment has not previously been reported in a patient with AVM post molar gestation. Case 
Presentation: A 23-year-old woman was diagnosed with a large uterine arteriovenous malformation 
following a suction curettage for a molar pregnancy. Complete resolution of the lesion on imaging was seen 
after six weeks of medical management. Conclusion: A uterine arteriovenous malformation can develop in 
a patient post complete molar pregnancy and can be successfully treated with medical management.